Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools ACC

ACC

Programs, trials, and reported response and survival for adenoid cystic carcinoma.

Data as of 11.07.2026

All studies

CB-103

CB-103 Phase 1/2 (terminated)

Cellestia Biotech · Phase 1/2 · Terminated · Enrollment 79

NCT03422679

ArmPopulationDoseEstimandComparatorEfficacy

No efficacy figure is in this file for this study.